SPECIFICITY OF THE THIOESTER-CONTAINING REACTIVE-SITE OF HUMAN C3 AND ITS SIGNIFICANCE TO COMPLEMENT ACTIVATION

被引:84
作者
SAHU, A
KOZEL, TR
PANGBURN, MK
机构
[1] UNIV TEXAS,HLTH SCI CTR,DEPT BIOCHEM,TYLER,TX 75710
[2] UNIV NEVADA,DEPT MICROBIOL,RENO,NV 89557
关键词
D O I
10.1042/bj3020429
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The specificity of the thioester-containing site in three plasma proteins is regulated by elements of their protein structures other than the thioester bond itself. Human C4A and alpha 2-macroglobulin preferentially form amide linkages while human C3 primarily forms ester linkages with hydroxyl groups. We have examined the thioester in C3 and found evidence of strong preferences for certain carbohydrates, indications of selectivity for specific positions on those carbohydrates and a preference for terminal sugars in polysaccharides. A testable set of rules are derived from these findings which predict preferred attachment sites on polysaccharides. A computer model of the effect of different reactivities on activation of the alternative pathway of complement suggested that organisms might greatly alter their susceptibility to complement with small changes in carbohydrate structure. While a random selection of 20 biological particles showed no correlation between activation and C3b attachment efficiency, subsets of related organisms differing primarily in their surface polysaccharide exhibited stronger correlations. The strongest correlation occurred in a series of the yeasts (Cryptococcus neoformans) possessing capsular polysaccharides with one, two, three or four branching xylose sugars per repeating unit. These organisms exhibited capture efficiencies for metastable C3b from 12% (one-xylose strain) to 41% (four-xylose strain).
引用
收藏
页码:429 / 436
页数:8
相关论文
共 59 条
[1]  
ARNAOUT MA, 1981, J IMMUNOL, V127, P1348
[2]  
BHATTACHARJEE AK, 1984, REV INFECT DIS, V6, P619
[3]   PATHOGENESIS OF CAMPYLOBACTER-FETUS INFECTIONS - FAILURE OF ENCAPSULATED CAMPYLOBACTER FETUS TO BIND C3B EXPLAINS SERUM AND PHAGOCYTOSIS RESISTANCE [J].
BLASER, MJ ;
SMITH, PF ;
REPINE, JE ;
JOINER, KA .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (05) :1434-1444
[4]  
CAPEL PJA, 1978, J IMMUNOL, V121, P2566
[5]   SUBSTITUTION OF A SINGLE AMINO-ACID (ASPARTIC-ACID FOR HISTIDINE) CONVERTS THE FUNCTIONAL-ACTIVITY OF HUMAN-COMPLEMENT C4B TO C4A [J].
CARROLL, MC ;
FATHALLAH, DM ;
BERGAMASCHINI, L ;
ALICOT, EM ;
ISENMAN, DE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) :6868-6872
[6]   A GALACTOXYLOMANNAN ANTIGEN OF CRYPTOCOCCUS-NEOFORMANS SEROTYPE-A [J].
CHERNIAK, R ;
REISS, E ;
TURNER, SH .
CARBOHYDRATE RESEARCH, 1982, 103 (02) :239-250
[7]   COMPLEMENT EVASION STRATEGIES OF MICROORGANISMS [J].
COOPER, NR .
IMMUNOLOGY TODAY, 1991, 12 (09) :327-331
[8]   STRUCTURAL BASIS OF THE BINDING-SPECIFICITY OF THE THIOESTER-CONTAINING PROTEINS, C-4, C-3 AND ALPHA-2-MACROGLOBULIN [J].
DODDS, AW ;
LAW, SKA .
COMPLEMENT, 1988, 5 (02) :89-97
[9]   REGULATION BY MEMBRANE SIALIC-ACID OF BETA-1H-DEPENDENT DECAY-DISSOCIATION OF AMPLIFICATION C3 CONVERTASE OF ALTERNATIVE COMPLEMENT PATHWAY [J].
FEARON, DT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (04) :1971-1975
[10]   LYSIS OF ERYTHROCYTES BY COMPLEMENT IN ABSENCE OF ANTIBODY [J].
GOTZE, O ;
MULLEREB.HJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1970, 132 (05) :898-+